Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-28 Purchase | 2023-08-28 4:39 pm | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 14,705 | $6.7976 | $99,959 | 21,688 (Direct) | View |
| 2023-02-08 Sale | 2023-02-10 4:55 pm | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 4,267 | $13.89 | $59,272 | 6,983 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-02 Option Award | 2026-02-06 6:02 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 439,600 | $0 | 439,600 (Direct) | View |
| 2026-02-03 Tax Withholding | 2026-02-05 4:48 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 5,937 | $3.47 | 254,885 (Direct) | View |
| 2026-02-03 Exercise | 2026-02-05 4:48 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 20,875 | $0 | 254,885 (Direct) | View |
| 2026-02-01 Tax Withholding(A) | 2026-02-05 4:38 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 10,686 | $3.51 | 214,322 (Direct) | View |
| 2026-02-01 Exercise(A) | 2026-02-05 4:38 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 33,500 | $0 | 214,322 (Direct) | View |
| 2025-02-01 Tax Withholding | 2026-02-03 5:34 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 15,980 | $2.48 | 102,773 (Direct) | View |
| 2025-02-01 Tax Withholding(A) | 2026-02-03 5:32 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 15,980 | $2.48 | 102,773 (Direct) | View |
| 2026-01-02 Tax Withholding | 2026-01-05 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 6,171 | $2.88 | 173,741 (Direct) | View |
| 2025-12-31 Tax Withholding | 2026-01-05 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 33,994 | $3.01 | 173,741 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 91,900 | $0 | 173,741 (Direct) | View |
| 2025-02-01 Tax Withholding | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 15,447 | $2.48 | 549,606 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 375,800 | $0 | 549,606 (Direct) | View |
| 2025-02-01 Exercise | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 33,500 | $0 | 549,606 (Direct) | View |
| 2024-12-31 Tax Withholding | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 40,664 | $2.48 | 250,853 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 55,000 | $0 | 250,853 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 91,900 | $0 | 250,853 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-05 7:29 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 6,421 | $1.2 | 492,017 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:29 pm | N/A 2034-01-31 | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 413,000 | $0 | 492,017 (Direct) | View |
| 2024-02-01 Exercise | 2024-02-05 7:29 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 18,750 | $0 | 492,017 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:01 pm | N/A 2033-01-31 | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 135,000 | $0 | 180,000 (Direct) | View |
| 2023-02-01 Exercise | 2023-02-03 5:01 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 11,250 | $0 | 180,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-01 4:50 pm | N/A 2032-01-31 | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-07-08 Tax Withholding | 2021-07-12 4:15 pm | N/A N/A | Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development | 731 | $43.24 | 8,592 (Direct) | View |
| 2021-07-08 Exercise | 2021-07-12 4:15 pm | N/A N/A | Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development | 3,000 | $0 | 8,592 (Direct) | View |
| 2021-03-09 Option Award | 2021-03-11 5:14 pm | N/A N/A | Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development | 23,507 | $0 | 23,507 (Direct) | View |